Stocks · Korea
036480
KOSDAQ
Daesung Microbiological Labs
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER38.41x
PBR0.65x
EPS157 KRW
BPS9,321 KRW
ROE2.47%
Dividend yield1.24%
DPS75 KRW
Payout ratio47.77%
Returns and 52-week range
1W-1.15%
1M-3.37%
3M-3.83%
6M-24.34%
1Y-24.34%
YTD-17.06%
52W high10,960원
52W low5,400원
From 52W high-44.98%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 255억 | -3억 | 0원 | -1.3% |
| 2023 | 256억 | -7억 | 0원 | -2.7% |
| 2024 | 238억 | -16억 | -18억 | -6.5% |
| 2025 | 260억 | 7억 | 6억 | 2.8% |
| Quarterly | ||||
| 2024 4Q | 68억 | 7억 | -15억 | 10.7% |
| 2025 1Q | 52억 | -3억 | -3억 | -6.4% |
| 2025 2Q | 67억 | 7억 | -1억 | 10.9% |
| 2025 3Q | 72억 | 6억 | 8억 | 8.2% |
| 2025 4Q | 69억 | -3억 | 2억 | -3.9% |
| 2026 1Q | 51억 | -5억 | 0원 | -10.2% |
Company
Address: 경기도 의왕시 덕영대로 103
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 에이프로젠바이오로직스 | 250억 | — | 0.10 | -10.83% |
| 텔콘RF제약 | 227억 | — | 0.15 | +3.37% |
| 샤페론 | 252억 | — | 1.02 | +6.67% |
| 서울제약 | 225억 | 29.75 | 0.55 | -1.07% |
| 제놀루션 | 269억 | — | 0.37 | +3.62% |
| 풍전약품 | 225억 | 77.83 | 0.57 | -7.34% |
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.